Kymera Therapeutics, Inc.
KYMR
Rank in Stocks
#2249
Kymera Therapeutics, Inc. is a biopharmaceutical company dedicated to... Kymera Therapeutics, Inc. is a biopharmaceutical company dedicated to discovering and developing pioneering small molecule therapeutics. These treatments operate by harnessing the body's inherent protein degradation system to selectively eliminate disease-causing proteins. The company's pipeline features several programs, including the IRAK4 program, currently in Phase I clinical trials, which targets various immunology-inflammation disorders such as hidradenitis suppurativa, atopic dermatitis, macrophage activation syndrome, generalized pustular psoriasis, and rheumatoid arthritis. Additionally, Kymera is advancing its IRAKIMiD program, designed to address MYD88-mutated diffuse large B cell lymphoma. Other key programs include the STAT3 program, focused on hematological malignancies, solid tumors, autoimmune diseases, and fibrosis, as well as the MDM2 program, which is also aimed at hematological malignancies and solid tumors. The company was founded in 2015 and maintains its headquarters in Watertown, Massachusetts.
Share Price
$108.61
Last synced: 2026-10-19
Market Cap
$8.93B
Change (1 day)
3.65%
Change (1 year)
79.51%
Country
US
Trade Kymera Therapeutics, Inc. (KYMR)
Category
Healthcare
Stock split history for Kymera Therapeutics, Inc. (KYMR)
Kymera Therapeutics, Inc. stock (symbol: KYMR) underwent a total of 0 stock splits.
The most recent stock split occurred on Oct 20, 2026.
One KYMR share bought prior to Oct 20, 2026 would equal to 0 KYMR shares today.
The most recent stock split occurred on Oct 20, 2026.
One KYMR share bought prior to Oct 20, 2026 would equal to 0 KYMR shares today.
Stock split list
| Year | Split | Multiple | Cumulative Multiple |
|---|---|---|---|
| Not enough data for the provided dates. | |||
Stock splits for similar companies or competitors
| Company | Number of stock splits | Cumulative Multiple | Country |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
CH
|
|
| 0 | - |
NL
|
